Shares of Sarepta Therapeutics Inc. (NASDAQ: SRPT), a biopharmaceutical company focused on rapidly advancing the development of its disease-modifying Duchenne muscular dystrophy drug candidates, surged in trading today.
Continue reading Major Gainers and Losers on August 30; SRPT, CIEN, SHLD, VC, TGT, FB